<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39439527</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2045-452X</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Toxicology research</Title><ISOAbbreviation>Toxicol Res (Camb)</ISOAbbreviation></Journal><ArticleTitle>Effects of Immunotoxicity biomarkers, essential elements and vitamin D levels on the severity levels of COVID-19 disease in Turkey.</ArticleTitle><Pagination><StartPage>tfae177</StartPage><MedlinePgn>tfae177</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">tfae177</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/toxres/tfae177</ELocationID><Abstract><AbstractText>Many mechanisms are thought to play a role in the pathogenesis of the COVID-19 pandemic, which started in 2019 and affected the whole world. It has been claimed that a deficiency in the immune system can significantly affect the severity of COVID-19 disease. It is important that the levels of essential elements and vitamin D are at certain levels for the healthy functioning of the immune system. Therefore, in this study, it was aimed to evaluate immunotoxicity biomarkers (tumor necrosis factor-alpha (TNF-α), interleukin (IL)-10, interferon (IFN)-γ, monocyte chemotactic protein-1 (MCP-1)), vitamin D, and essential element levels in COVID-19 patients in Turkey. According to the results of the study, it was found that the magnesium (Mg), zinc (Zn), and selenium (Se) levels decreased as the severity of the disease worsened, while the iron (Fe), and copper (Cu) levels were similar to the mild group and the control group, and the levels decreased as the disease worsened. It has also been found that vitamin D levels decrease as the severity of the disease worsens. Compared to the control group, TNF-α, MCP-1, and IFN-γ levels were found to decrease as the severity of the disease worsened. Also, it was observed that there was a significant relationship between essential metal levels and disease progression in most of the patient groups.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Secerlı</LastName><ForeName>Jülide</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4875-2266</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Çetinkaya</LastName><ForeName>Serdar</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9469-5066</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leblebici</LastName><ForeName>İlknur Sıla</ForeName><Initials>İS</Initials><Identifier Source="ORCID">0000-0003-3752-1777</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdemir</LastName><ForeName>Latif Alperen</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0009-0002-6781-5960</Identifier><AffiliationInfo><Affiliation>Department of Chest Diseases, University of Health Sciences Turkey, Gülhane Research and Training Hospital, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yücel</LastName><ForeName>Çiğdem</ForeName><Initials>Ç</Initials><Identifier Source="ORCID">0000-0003-2647-440X</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Biochemistry, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karaismailoğlu</LastName><ForeName>Eda</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3085-7809</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of Health Sciences Turkey, Gülhane Faculty of Medicine, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kara</LastName><ForeName>Umut</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-5233-8255</Identifier><AffiliationInfo><Affiliation>General Intensive Care Unit, Special Acıbadem Ataşehir Hospital, 34758 İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özcan</LastName><ForeName>Aydan</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1868-0617</Identifier><AffiliationInfo><Affiliation>Department of Sports Medicine, University of Health Sciences Turkey, Gülhane Faculty of Medicine, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Öcal</LastName><ForeName>Nesrin</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3789-7769</Identifier><AffiliationInfo><Affiliation>Department of Chest Diseases, University of Health Sciences Turkey, Gülhane Research and Training Hospital, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arslan</LastName><ForeName>Yakup</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7614-1198</Identifier><AffiliationInfo><Affiliation>Department of Chest Diseases, University of Health Sciences Turkey, Gülhane Research and Training Hospital, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Şenkal</LastName><ForeName>Serkan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4571-3923</Identifier><AffiliationInfo><Affiliation>General Intensive Care Unit, Special Acıbadem Ataşehir Hospital, 34758 İstanbul, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdem</LastName><ForeName>Onur</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-5849-3552</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacanlı</LastName><ForeName>Merve Güdül</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-8757-0572</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Toxicology, University of Health Sciences Turkey, Gülhane Faculty of Pharmacy, 06018 Ankara, Türkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Toxicol Res (Camb)</MedlineTA><NlmUniqueID>101587950</NlmUniqueID><ISSNLinking>2045-452X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Essential element</Keyword><Keyword MajorTopicYN="N">Immunotoxicity</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39439527</ArticleId><ArticleId IdType="pmc">PMC11491277</ArticleId><ArticleId IdType="doi">10.1093/toxres/tfae177</ArticleId><ArticleId IdType="pii">tfae177</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu F, Zhao S, Yu B, Chen Y, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, et al. . A new coronavirus associated with human respiratory disease in China. Nature. 2020:579(7798):265–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M, Al Khodor S. Pathophysiology and treatment strategies for COVID-19. J Transl Med. 2020:18(1):1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491044</ArticleId><ArticleId IdType="pubmed">32933536</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Jiao B, Qu L, Yang D, Liu R. The development of COVID-19 treatment. Front Immunol. 2023:14:14–27. 10.3389/FIMMU.2023.1125246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2023.1125246</ArticleId><ArticleId IdType="pmc">PMC9909293</ArticleId><ArticleId IdType="pubmed">36776881</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Wu X, Zheng X, Luo S, Xu S, Weng J. Targeting inflammation and cytokine storm in COVID-19. Pharmacol Res. 2020:159:1–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320704</ArticleId><ArticleId IdType="pubmed">32603772</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. . COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduction Targeted Ther. 2020:5(1):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381863</ArticleId><ArticleId IdType="pubmed">32712629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, Grupp SA, Mackall CL. Current concepts in the diagnosis and management of cytokine release syndrome. J Am Soc Hematol. 2014:124(2):188–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4093680</ArticleId><ArticleId IdType="pubmed">24876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannas D, Loi E, Serra M, Firinu D, Valera P, Zavattari P. Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk. Nutrients. 2020:12(7):2074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400883</ArticleId><ArticleId IdType="pubmed">32668647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmalingam K, Birdi A, Tomo S, Sreenivasulu K, Charan J, Yadav D, Purohit P, Sharma P. Trace elements as Immunoregulators in SARS-CoV-2 and other viral infections. Indian J Clin Biochem. 2021:1-11(4):416–26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879594</ArticleId><ArticleId IdType="pubmed">33613002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Dong X, Liu G, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023:64(1):90–107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8767775</ArticleId><ArticleId IdType="pubmed">35044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Amer Y, Bar-Shavit Z. Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency. Cell Immunol. 1993:151(2):356–68.</Citation><ArticleIdList><ArticleId IdType="pubmed">8402942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber-Bzura BM. Vitamin D and influenza—prevention or therapy? Int J Mol Sci. 2018:19(8):2419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6121423</ArticleId><ArticleId IdType="pubmed">30115864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Liu T, Yao L, Xing Y, Zhao X, Fu J, Xue X. Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system. Sci Rep. 2017:7(1):3312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468249</ArticleId><ArticleId IdType="pubmed">28607392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannell JJ, Vıeth R, Umhau JC, Holıck MF, Grant WB, Madronıch S, et al. . Epidemic influenza and vitamin D. Epidemiol Infect. 2006:134(6):1129–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2870528</ArticleId><ArticleId IdType="pubmed">16959053</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, et al. . Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. The. BMJ. 2017:356:i6583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310969</ArticleId><ArticleId IdType="pubmed">28202713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020:32(7):1195–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202265</ArticleId><ArticleId IdType="pubmed">32377965</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of Vitamin D Status and Other Clinical Characteristics with COVID-19 test results. JAMA Netw Open. 2020:3(9):e2019722–e2019722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489852</ArticleId><ArticleId IdType="pubmed">32880651</ArticleId></ArticleIdList></Reference><Reference><Citation>Giménez V, Inserra F, Tajer C, Mariani J, Ferder L, Reiter RJ, Manucha W. Lungs as target of COVID-19 infection: protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. 2020:254:117808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227533</ArticleId><ArticleId IdType="pubmed">32422305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye K, Tang F, Liao X, Shaw BA, Deng M, Huang G, Qin Z, Peng X, Xiao H, Chen C, et al. . Does serum vitamin D level affect COVID-19 infection and its severity?-a case-control study. J Am Coll Nutr. 2021:40(8):724–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33048028</ArticleId></ArticleIdList></Reference><Reference><Citation>Duydu Y, Başaran N, Aydın S, Üstündağ A, Yalçın CÖ, Anlar HG, Bacanlı M, Aydos K, Atabekoğlu CS, Golka K, et al. . Evaluation of FSH, LH, testosterone levels and semen parameters in male boron workers under extreme exposure conditions. Arch Toxicol. 2018:92(10):3051–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30143848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocak, OF, Ozgeris FB, Parlak E, Kadıoglu Y, Yuce N, Yaman ME, Bakan E. Evaluation of serum trace element levels and biochemical parameters of COVID-19 patients according to disease severity. Biol Trace Elem Res. 2022:1-9(7):3138–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8489790</ArticleId><ArticleId IdType="pubmed">34608570</ArticleId></ArticleIdList></Reference><Reference><Citation>Finzi E. Treatment of SARS-CoV-2 with high dose oral zinc salts: a report on four patients. Int J Infect Dis. 2020:99:307–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834648</ArticleId><ArticleId IdType="pubmed">32522597</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao JS, Paguio JA, Dee EC, Tan HC, Moulick A, Milazzo C, Jurado J, Della Penna N, Celi LA. The minimal effect of zinc on the survival of hospitalized patients with COVID-19: an observational study. Chest. 2021:159(1):108–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375307</ArticleId><ArticleId IdType="pubmed">32710890</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, Jani BD, Welsh P, Mair FS, Gray SR, et al. . Vitamin D concentrations and COVID-19 infection in UK biobank. Diabetes Metab Syndr Clin Res Rev. 2020:14(4):561–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204679</ArticleId><ArticleId IdType="pubmed">32413819</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>